Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer International Publishing
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513191/ |